Baxdrostat 17228-6002
Product NDC
17228-6002- Manufacturer
- Astrazeneca Ab
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- November 18, 2025
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Baxdrostat | 2 mg/1 |
Packaging Options(1)
47000 TABLET, FILM COATED in 1 CARTON (17228-6002-0)